The molecular mechanisms of human neurodegenerative diseases have so far been studied in animals models but the validity of extrapolating these studies to human in uncertain. There is a need, therefore, to study human neurons at the cellular and molecular levels of understanding their normal behavior and functioning and the changes which lead to neurodegenerative diseases. The neurodegenerative effects of BetaA or its peptide fragments in vitro have mostly been studied on rat neuronal cells or tissue slices and only in few instances on human cells cultured from cryopreserved brains. Propagation and establishment of long-term cultures of human neurons promises to be a powerful approach in achieving this goal. We propose to propagate and establish long-term cultures of human neuronal cells by utilizing the proliferative property of basic fibroblast growth factor (bFGF). Cell will be characterized according to morphology and phenotypes. Establishment of such cultures will enable us to generate large number of cells from specific areas of the brain using small amounts of scarce fetal tissues. We have already succeeded in propagating and establishing long-term neuronal cultures from rat brain tissues. We will transduce amyloid precursor protein (APP) and Beta-amyloid (BetaA) genes into human and rat neurons and study both the expression of these proteins at the molecular levels and their modulation by factors such as the state of differentiation and growth factors. In In vitro experiments BetaA peptides will be added to neuronal cultures to determine their neurodegenerative effects. The neurotoxic effects of glutamate, a neurotransmitter, on cultured neurons (control) or neuron expressing APP proteins (test) in the absence and in the presence of bFGF will be studied. Parallel cultures of human and rat neuronal cultures will be used for these studies and the results will be compared. This will allow us to determine whether rat neurons can be used as model for studies of human neurodegenerative diseases at the molecular level. The establishment of perpetual human neuronal cultures will enable the studies of their functioning at the cellular and molecular level in general and, specific to this proposal, an understanding of the modulation of BetaA by environmental effectors including neurotransmitter and growth factors.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
5P50AG005131-15
Application #
6267256
Study Section
Project Start
1998-04-15
Project End
1999-03-31
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
15
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of California San Diego
Department
Type
DUNS #
077758407
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Hadjichrysanthou, Christoforos; McRae-McKee, Kevin; Evans, Stephanie et al. (2018) Potential Factors Associated with Cognitive Improvement of Individuals Diagnosed with Mild Cognitive Impairment or Dementia in Longitudinal Studies. J Alzheimers Dis 66:587-600
Chen, Xu-Qiao; Fang, Fang; Florio, Jazmin B et al. (2018) T-complex protein 1-ring complex enhances retrograde axonal transport by modulating tau phosphorylation. Traffic 19:840-853
Hanfelt, John J; Peng, Limin; Goldstein, Felicia C et al. (2018) Latent classes of mild cognitive impairment are associated with clinical outcomes and neuropathology: Analysis of data from the National Alzheimer's Coordinating Center. Neurobiol Dis 117:62-71
Zhou, Zilu; Wang, Weixin; Wang, Li-San et al. (2018) Integrative DNA copy number detection and genotyping from sequencing and array-based platforms. Bioinformatics 34:2349-2355
Burke, Shanna L; Hu, Tianyan; Fava, Nicole M et al. (2018) Sex differences in the development of mild cognitive impairment and probable Alzheimer's disease as predicted by hippocampal volume or white matter hyperintensities. J Women Aging :1-25
Wang, Qi; Guo, Lei; Thompson, Paul M et al. (2018) The Added Value of Diffusion-Weighted MRI-Derived Structural Connectome in Evaluating Mild Cognitive Impairment: A Multi-Cohort Validation1. J Alzheimers Dis 64:149-169
Besser, Lilah; Kukull, Walter; Knopman, David S et al. (2018) Version 3 of the National Alzheimer's Coordinating Center's Uniform Data Set. Alzheimer Dis Assoc Disord 32:351-358
Sundermann, Erin E; Tran, My; Maki, Pauline M et al. (2018) Sex differences in the association between apolipoprotein E ?4 allele and Alzheimer's disease markers. Alzheimers Dement (Amst) 10:438-447
Edmonds, Emily C; Weigand, Alexandra J; Thomas, Kelsey R et al. (2018) Increasing Inaccuracy of Self-Reported Subjective Cognitive Complaints Over 24 Months in Empirically Derived Subtypes of Mild Cognitive Impairment. J Int Neuropsychol Soc 24:842-853
Graves, Lisa V; Van Etten, Emily J; Holden, Heather M et al. (2018) Refining CVLT-II recognition discriminability indices to enhance the characterization of recognition memory changes in healthy aging. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn 25:767-782

Showing the most recent 10 out of 914 publications